Thermal proteome profiling and proteome analysis using high‐definition mass spectrometry demonstrate modulation of cholesterol biosynthesis by next‐generation galeterone analog VNPP 433‐3β in castration‐resistant prostate cancer
Molecular Oncology · 2025
DOI: 10.1002/1878-0261.70009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Oncology, 2025. Verfasst von Retheesh S Thankan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of Maryland School of Medicine, Baltimore, MD, USA. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Castration-Resistant, Proteome, Cholesterol, Proteomics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, National Institutes of Health (NIH), USA and the National Cancer Institute (NCI), USA.
Abstract (Originalsprache)
Cholesterol (CHOL) homeostasis is significantly modulated in prostate cancer (PCa) suggesting an active role in PCa development and progression. Several studies indicate a strong correlation between elevated CHOL levels and increased PCa risk and severity. Inhibition of CHOL biosynthesis at different steps, including lanosterol synthase (LSS), has shown significant efficacy against both hormone‐dependent and castration‐resistant PCa. Earlier, we reported proteasomal degradation of androgen receptor (AR)/AR‐Vs and Mnk1/2 as the primary mechanisms of action of VNPP433‐3β in inhibiting PCa cell proliferation and tumor growth. Through thermal proteome profiling, comparative proteomics and cellular thermal shift assay, we identified VNPP433‐3β's ancillary effect of lowering CHOL by binding to LSS and lanosterol 14‐alpha demethylase, potentially inhibiting CHOL biosynthesis in PCa cells and tumors. Additionally, in conjunction with our previously reported transcriptome analysis, proteomics reveals that VNPP433‐3β modulated upstream regulators and pathways critical for PCa stem cell maintenance and recurrence. The inhibition of CHOL biosynthesis by VNPP433‐3β reinforces its multifaceted effects in PCa across all stages, highlighting its potential as a single‐agent therapy. Achieving reduced CHOL levels aligns with better treatment outcomes, further substantiating VNPP433‐3β's therapeutic potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, University of Maryland School of Medicine, Baltimore, MD, USA.
- Isoprene Pharmaceuticals, Inc., University of Maryland Baltimore BioPark, Baltimore, MD, USA.
- The Center for Biomolecular Therapeutics, University of Maryland School of Medicine, Baltimore, MD, USA.
- Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD, USA.
- Division of Biostatistics and Bioinformatics, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
- Department of Microbiology and Immunology, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
ORCID-Profile: Elizabeth Thomas, Vincent C O Njar
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- National Institutes of Health (NIH), USA and the National Cancer Institute (NCI), USA
Zitieren
APA
Thankan, R. S., Thomas, E., Weldemariam, M. M., Purushottamachar, P., Huang, W., Kane, M. A., Zhang, Y., Ambulos, N., Wang, B. D., Weber, D., & Njar, V. C. O. (2025). Thermal proteome profiling and proteome analysis using high‐definition mass spectrometry demonstrate modulation of cholesterol biosynthesis by next‐generation galeterone analog VNPP 433‐3β in castration‐resistant prostate cancer. Molecular Oncology. https://doi.org/10.1002/1878-0261.70009
Vancouver
Thankan RS, Thomas E, Weldemariam MM, Purushottamachar P, Huang W, Kane MA, et al. Thermal proteome profiling and proteome analysis using high‐definition mass spectrometry demonstrate modulation of cholesterol biosynthesis by next‐generation galeterone analog VNPP 433‐3β in castration‐resistant prostate cancer. Molecular Oncology. 2025. doi:10.1002/1878-0261.70009
BibTeX
@article{Thankan2025,
author = {Thankan, Retheesh S and Thomas, Elizabeth and Weldemariam, Mehari M and Purushottamachar, Puranik and Huang, Weiliang and Kane, Maureen A and Zhang, Yuji and Ambulos, Nicholas and Wang, Bi-Dar and Weber, David and Njar, Vincent C O},
title = {Thermal proteome profiling and proteome analysis using high‐definition mass spectrometry demonstrate modulation of cholesterol biosynthesis by next‐generation galeterone analog VNPP 433‐3β in castration‐resistant prostate cancer},
journal = {Molecular Oncology},
year = {2025},
doi = {10.1002/1878-0261.70009}
}
EUVIMED